Shortage of lansoprazole orally disintegrating tablets

The American Society of Health-System Pharmacists reports a shortage of lansoprazole orally disintegrating tablets. This particular presentation of lansoprazole is very important for the treatment of gastroesophageal reflux disease, commonly called heartburn, but uncommonly serious in some people whose esophagus is constantly exposed to stomach acid. This results in burns, ulcers and swallowing difficulties. The significant fact is that this drug formulation disintegrates in the mouth and can be taken without swallowing water. The shortage is caused in part by the voluntary withdrawal from the market of Teva's product earlier this year. The FDA notice explains in detail. Sandoz provided no reason for their shortage.